The development of novel and effective and safe therapies for the treatment of cancer is one of the main challenges for modern medicine. We want to drive this process forward. The main goal of Tubulis is to become a leading company in the field of targeted therapeutics and antibody-drug conjugates (ADCs). With a strong team, our own technologies and innovative therapeutic concepts, we are ushering in a new era in the ongoing fight against cancer and share the vision of helping patients worldwide. Be part of a multidisciplinary and focused team, that works towards getting novel promising ADCs to patients with solid and hematological cancers.
We are looking for a proactive and committed Senior MD, MD PhD or PhD with strong experience in global clinical development of Biologics such as Antibody Drug Conjugates (ADCs), to drive and lead the global clinical development strategy of TUB-010, a novel CD30-ADC, and to help develop the emerging pipeline of Tubulis. This GCL will report to the CMO.
Besides an exciting working and team environment which is guided by the common goal to develop new medicines that will help patients in need, we offer a competitive salary and support for your personal and professional development.
Please send a digital copy of your application including a CV, a comprehensive letter of motivation, a summary of your experience and your availability to firstname.lastname@example.org. We are looking forward to your application.